Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

44,990 stories, page 629 of 750

Advanced search

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.

PBSOriginal source

🌍Jun 30Mediaechonous.comTier 2 · Direct publisher

Advancing Perioperative Ultrasound: Dr. Deepak Borde on AI and Echoliteracy

EchoNousOriginal source

🇺🇰Jun 30Regulatorygov.ukTier 1 · Regulatory source

UK’s first maternity and neonatal commissioner to be appointed

New commissioner and extra funding announced to make maternity and neonatal care safer, fairer and m...

UK Department of Health and Social CareOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Cellid Crashes After-Hours on Phase 3 Failure...Shaperon Dives 25%[K-bio pulse]

이데일리Original source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

French biotech company Ipsen to buy Kartos Therapeutics for $450 million

ReutersOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Biotech Is The Rate Cut Trade In Disguise

Seeking AlphaOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Abivax reports phase 3 ulcerative colitis trial results

Investing.com UKOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

FDA extends Praxis (NASDAQ: PRAX) relutrigine review deadline to Dec 27, 2026

Stock TitanOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request

The Manila TimesOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Suspends Licences Of 6 Mumbai Eateries Over Rat Infestation, Expired Food, And Unhygienic

Free Press JournalOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

FDA’s Drug Repurposing Initiative Signals a Shift in Regulatory Strategy

JD SupraOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

PBM lobby goes on the offensive

The HillOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

The EU’s Biotech Act (Part 2): compelling changes to clinical trial regulation

IQVIAOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Silo Pharma tests nasal spray device for PTSD drug ahead of FDA meeting

Stock TitanOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Silo Pharma Advances SPC-15 PTSD Therapeutic with

GlobeNewswireOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Abivax’s ulcerative colitis drug shows benefit in hard-to-treat patients

Stock TitanOriginal source

🌍Jun 30discoverynews.google.comTier 2 · Trade media

Ipsen’s $450M Deal Brings Drug That Could Make a Standard Blood Cancer Therapy Better

MedCity NewsOriginal source

🇺🇰Jun 30Regulatorygov.ukTier 1 · Regulatory source

Resident doctors agree deal with government to end strikes

BMA votes to accept offer that will see resident doctors benefit from new pay structure and better c...

UK Department of Health and Social CareOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Vancouver biotech Zymeworks buying Theravance for US$929M

Business in VancouverOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

DEA And FDA Highlight How Marijuana Is Safer Than Alcohol And Opioids During Rescheduling Hearing's Opening Day

Marijuana MomentOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Gerren McHam: What Effective Pharma Reshoring Actually Requires

Pharmaceutical CommerceOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

UNCY Stock Rallies 8% As Retail Traders Anticipate FDA Clearance For Lead Drug Candidate

TradingViewOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Ipsen Enters Merger Agreement to Acquire Kartos Therapeutics | PharmExec

Pharmaceutical ExecutiveOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Sagimet Biosciences added to Russell 2000 and 3000 indexes

Investing.com UKOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

COMP360, REMS and What FDA Psychedelic Approval Path Means for Investors and Operators

JD SupraOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Pediatric clinical trial update: Q2 2026

Contemporary PediatricsOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Maharashtra Orders Statewide Blood Bank Inspection Drive After FDA Crackdown On Safety Violations

Free Press JournalOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

The Biotech Winter Finally Thaws

Brownstone ResearchOriginal source

🌍Jun 30discoverynews.google.comTier 2 · Trade media

FDA issues complete response letter to Sobi’s NASP for gout

Pharmaceutical TechnologyOriginal source

🌍Jun 30discoverynews.google.comTier 2 · Trade media

Lilly’s Jaypirca receives CHMP positive opinion for CLL in Europe

Pharmaceutical TechnologyOriginal source

🇪🇺Jun 30Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106

CORDISOriginal source

🇪🇺Jun 30Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: SInGle cells iN AuToimmUne inflammatoRy disEases

CORDISOriginal source

🇪🇺Jun 30Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Targeting Circadian Clock Dysfunction in Alzheimer’s Disease

CORDISOriginal source

🇪🇺Jun 30Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Doctoral network for microprocess engineering for electrosynthesis - new synthesis concepts for pharmaceutical/ fine chemical industry

CORDISOriginal source

🇪🇺Jun 30Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: NEXT GENERATION VACCINES AGAINST GASTROINTESTINAL MUCOSAL PATHOGENS, USING HELICOBACTER PYLORI AS MODEL PATHOGEN

CORDISOriginal source

🇪🇺Jun 30Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Immunopeptidomics-based Development of Next-Generation Bacterial mRNA Vaccines

CORDISOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Why I’m Eyeing Prices, Biotech and AI in Q3

TheStreet ProOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Biodexa Pharmaceuticals (BDRX) Expands Phase 3 Clinical Trial to Canada

GuruFocusOriginal source

🇺🇰Jun 29Regulatorygov.ukTier 1 · Regulatory source

Health Protection Report: current issue and latest surveillance reports

Routine reports, and commentary, on data from health protection surveillance schemes.

UK Health Security AgencyOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

EFPIA urges innovation-friendly approach in submission on EU Biotech Act II

The Pharma LetterOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Biotech Bigwigs ABBV, JNJ, BIIB & LLY Hit New 52-Week Highs

Yahoo FinanceOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

What's Standing Between Reshoring Ambitions and Reality?

Pharmaceutical CommerceOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class H

TradingViewOriginal source

🌍Jun 29discoverynews.google.comTier 2 · Trade media

FDA rejects Sobi’s gout drug over manufacturing issues, sparing Amgen blockbuster

Fierce PharmaOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

TNVitamins moringa supplement recall issued over salmonella risk, FDA says

Houston ChronicleOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

SYRE and Spyre Ride New IBD Trends in Biotech Drug Design

Zacks Investment ResearchOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Alpha-1 Antitrypsin Gene Editing Startup Raises $230 Million: Serapha Bio AATD Debut

Tech TimesOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Biodexa Pharmaceuticals (BDRX) Expands Phase 3 Clinical Trial to Canada

GuruFocusOriginal source

🌍Jun 29discoverynews.google.comTier 2 · Trade media

Biotech SPAC deal gets it to Nasdaq; AstraZeneca Phase 3 win in children's bone disease

Endpoints NewsOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Larimar Stock Slides 15% Despite FDA Backing Rolling Submission For Rare Disease Drug

BenzingaOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

DCOY Stock Explodes Higher As Volatile Biotech Trading Heats Up

StocksToTradeOriginal source

🌍Jun 29discoverynews.google.comTier 2 · Trade media

Evommune’s phase 2b trial flops, ending challenge to Novartis in hives

Fierce BiotechOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Talawar Tx launches as publicly traded biotech

The Pharma LetterOriginal source

🌍Jun 29discoverynews.google.comTier 2 · Trade media

Talawar bets bispecific approach can shake up eczema market

statnews.comOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Pro-Life States Get Victory Against Mail-Order Abortions in Appeals Court Ruling

lifenews.comOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

National formulary will make shortages worse, suggests NPA chair

The Pharmaceutical JournalOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Genentech-adjacent Japanese drugmaker sets up Peninsula office, looks for deals

The Business JournalsOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Lycia raises $75m as degrader pipeline moves toward patient data

The Pharma LetterOriginal source

🌍Jun 29discoverynews.google.comTier 2 · Trade media

United Therapeutics nabs FDA approval for donor-lung assessment device

Fierce BiotechOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Nashik: FDA Warns Food Businesses Of Strict Action Over Safety Violations; Says No Compromise On Public Health

Free Press JournalOriginal source